Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

America Walks: An Observational Study of Walking Behavior Based on Passive Step Tracking
America Walks: An Observational Study of Walking Behavior Based on Passive Step Tracking Using a Mobile Phone Application
Status: Enrolling
Updated:  1/12/2017
TrialX Inc
mi
from
New York, NY
America Walks: An Observational Study of Walking Behavior Based on Passive Step Tracking
America Walks: An Observational Study of Walking Behavior Based on Passive Step Tracking Using a Mobile Phone Application
Status: Enrolling
Updated: 1/12/2017
TrialX Inc
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy Participants
Randomized, Parallel-Group, 2-Part Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding Parameters and Pharmacodynamics After a Punch Biopsy Procedure in Healthy Subjects Treated With Rivaroxaban
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Overland Park, KA
A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy Participants
Randomized, Parallel-Group, 2-Part Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding Parameters and Pharmacodynamics After a Punch Biopsy Procedure in Healthy Subjects Treated With Rivaroxaban
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers
A Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect in Healthy Volunteers
Status: Enrolling
Updated:  1/23/2017
InVentiv Health
mi
from
Miami, FL
Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers
A Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect in Healthy Volunteers
Status: Enrolling
Updated: 1/23/2017
InVentiv Health
mi
from
Miami, FL
Click here to add this to my saved trials
Safety Study Designed to Study the Effects of Two Different Doses of CXA-101/Tazobactam, a Low Dose and a High Dose, on the QT/QTc Intervals in Healthy Subjects
A Double-Blind, Double-Dummy, Randomized, Moxifloxacin and Placebo Controlled, Four-Way Crossover Study of the Effects of a Single Intravenous Supra-Therapeutic Dose and Single Intravenous Therapeutic Dose of CXA-101/Tazobactam on the QT/QTC Intervals in Healthy Subjects
Status: Enrolling
Updated:  1/25/2017
Cetero Reserach
mi
from
Fargo, ND
Safety Study Designed to Study the Effects of Two Different Doses of CXA-101/Tazobactam, a Low Dose and a High Dose, on the QT/QTc Intervals in Healthy Subjects
A Double-Blind, Double-Dummy, Randomized, Moxifloxacin and Placebo Controlled, Four-Way Crossover Study of the Effects of a Single Intravenous Supra-Therapeutic Dose and Single Intravenous Therapeutic Dose of CXA-101/Tazobactam on the QT/QTC Intervals in Healthy Subjects
Status: Enrolling
Updated: 1/25/2017
Cetero Reserach
mi
from
Fargo, ND
Click here to add this to my saved trials
Environments as Smoking Cues: Imaging Brain Substrates, Developing New Treatments (CameraCue)
Environments as Smoking Cues: Imaging Brain Substrates, Developing New Treatments
Status: Enrolling
Updated:  1/30/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Environments as Smoking Cues: Imaging Brain Substrates, Developing New Treatments (CameraCue)
Environments as Smoking Cues: Imaging Brain Substrates, Developing New Treatments
Status: Enrolling
Updated: 1/30/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Paid Price Information on Image and Procedure Ordering Rates
The Effect of Paid Price Information on Image and Procedure Ordering Rates
Status: Enrolling
Updated:  1/30/2017
Boston Children's Hospital
mi
from
Boston, MA
Paid Price Information on Image and Procedure Ordering Rates
The Effect of Paid Price Information on Image and Procedure Ordering Rates
Status: Enrolling
Updated: 1/30/2017
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
The Effect of Neuraxial Analgesia on Maternal Breastfeeding
The Effect of Neuraxial Analgesia on Maternal Breastfeeding
Status: Enrolling
Updated:  1/31/2017
Northwestern University
mi
from
Chicago, IL
The Effect of Neuraxial Analgesia on Maternal Breastfeeding
The Effect of Neuraxial Analgesia on Maternal Breastfeeding
Status: Enrolling
Updated: 1/31/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate the Effect of Particle Size, Formulation and Food on the Pharmacokinetics of GDC-0032 in Healthy Volunteers
A Phase 1, Open-Label Study to Evaluate the Effect of Particle Size, Formulation, and Food on the Pharmacokinetics of GDC-0032 in Healthy Subjects
Status: Enrolling
Updated:  1/31/2017
Covance Research Unit - Dallas
mi
from
Dallas, TX
A Study to Evaluate the Effect of Particle Size, Formulation and Food on the Pharmacokinetics of GDC-0032 in Healthy Volunteers
A Phase 1, Open-Label Study to Evaluate the Effect of Particle Size, Formulation, and Food on the Pharmacokinetics of GDC-0032 in Healthy Subjects
Status: Enrolling
Updated: 1/31/2017
Covance Research Unit - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Effect of Azimilide Dihydrochloride on Renal Function
A Double-blind, Randomized, Parallel-group, Placebo-controlled, Multiple-dose Study to Assess the Effect of 125 mg/Day Orally Administered Azimilide Dihydrochloride on Renal Function and Hemodynamics in Healthy Volunteers
Status: Enrolling
Updated:  1/31/2017
Parexel CPRU, Harbor Hospital Center
mi
from
Baltimore, MD
Effect of Azimilide Dihydrochloride on Renal Function
A Double-blind, Randomized, Parallel-group, Placebo-controlled, Multiple-dose Study to Assess the Effect of 125 mg/Day Orally Administered Azimilide Dihydrochloride on Renal Function and Hemodynamics in Healthy Volunteers
Status: Enrolling
Updated: 1/31/2017
Parexel CPRU, Harbor Hospital Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, PK and PD of ALXN1007 in Healthy Subjects
A Phase 1, Randomized, Blinded, Placebo-Controlled, Single-Administration, Sequential-Cohort Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of ALXN1007 in Healthy Subjects
Status: Enrolling
Updated:  2/2/2017
PAREXEL Baltimore EPCU
mi
from
Baltimore, MD
Study to Evaluate Safety, Tolerability, PK and PD of ALXN1007 in Healthy Subjects
A Phase 1, Randomized, Blinded, Placebo-Controlled, Single-Administration, Sequential-Cohort Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of ALXN1007 in Healthy Subjects
Status: Enrolling
Updated: 2/2/2017
PAREXEL Baltimore EPCU
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cholecalciferol and Flu Vaccine in Treating Healthy Participants
Immune Responses to Influenza Vaccine Among Healthy Employees Working at Roswell Park Cancer Institute and the Relationship to Vitamin D Status
Status: Enrolling
Updated:  2/3/2017
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Cholecalciferol and Flu Vaccine in Treating Healthy Participants
Immune Responses to Influenza Vaccine Among Healthy Employees Working at Roswell Park Cancer Institute and the Relationship to Vitamin D Status
Status: Enrolling
Updated: 2/3/2017
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN®‐Filo in Healthy Adult Subjects
Status: Enrolling
Updated:  2/7/2017
Clinical Research Facility
mi
from
Huntsville, AL
A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN®‐Filo in Healthy Adult Subjects
Status: Enrolling
Updated: 2/7/2017
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN®‐Filo in Healthy Adult Subjects
Status: Enrolling
Updated:  2/7/2017
Clinical Research Facility
mi
from
Melbourne, FL
A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN®‐Filo in Healthy Adult Subjects
Status: Enrolling
Updated: 2/7/2017
Clinical Research Facility
mi
from
Melbourne, FL
Click here to add this to my saved trials
A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN®‐Filo in Healthy Adult Subjects
Status: Enrolling
Updated:  2/7/2017
Clinical Research Facility
mi
from
Peoria, IL
A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN®‐Filo in Healthy Adult Subjects
Status: Enrolling
Updated: 2/7/2017
Clinical Research Facility
mi
from
Peoria, IL
Click here to add this to my saved trials
A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN®‐Filo in Healthy Adult Subjects
Status: Enrolling
Updated:  2/7/2017
Clinical Research Facility
mi
from
Rockville, MD
A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN®‐Filo in Healthy Adult Subjects
Status: Enrolling
Updated: 2/7/2017
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN®‐Filo in Healthy Adult Subjects
Status: Enrolling
Updated:  2/7/2017
Clinical Research Facility
mi
from
San Diego, CA
A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN®‐Filo in Healthy Adult Subjects
Status: Enrolling
Updated: 2/7/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN®‐Filo in Healthy Adult Subjects
Status: Enrolling
Updated:  2/7/2017
Clinical Research Facility
mi
from
Mishawaka, IN
A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN®‐Filo in Healthy Adult Subjects
Status: Enrolling
Updated: 2/7/2017
Clinical Research Facility
mi
from
Mishawaka, IN
Click here to add this to my saved trials
A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants
A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) 1 x (50 mg/500 mg) With Respect to the Metformin XR Tablet (Locally Sourced From Canada [GLUMETZA, 1 x 500 mg]) Coadministered With Canagliflozin (1 x 50 mg) in Healthy Fed and Fasted Subjects
Status: Enrolling
Updated:  2/8/2017
Clinical Research Facility
mi
from
Tempe, AZ
A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants
A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) 1 x (50 mg/500 mg) With Respect to the Metformin XR Tablet (Locally Sourced From Canada [GLUMETZA, 1 x 500 mg]) Coadministered With Canagliflozin (1 x 50 mg) in Healthy Fed and Fasted Subjects
Status: Enrolling
Updated: 2/8/2017
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
Gastrointestinal Toleration of Inulin Products
Effect of Two Doses of Inulin Products on Gastrointestinal Tolerance
Status: Enrolling
Updated:  2/9/2017
University of Minnesota: Nutrition and Food Science Department
mi
from
Minneapolis, MN
Gastrointestinal Toleration of Inulin Products
Effect of Two Doses of Inulin Products on Gastrointestinal Tolerance
Status: Enrolling
Updated: 2/9/2017
University of Minnesota: Nutrition and Food Science Department
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety Study of LY3041658 in Healthy Participants
A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3041658 in Healthy Subjects
Status: Enrolling
Updated:  2/14/2017
PAREXEL-Phase 1 Baltimore Harbor Hospital Center
mi
from
Baltimore, MD
Safety Study of LY3041658 in Healthy Participants
A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3041658 in Healthy Subjects
Status: Enrolling
Updated: 2/14/2017
PAREXEL-Phase 1 Baltimore Harbor Hospital Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety Study of LY3041658 in Healthy Participants
A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3041658 in Healthy Subjects
Status: Enrolling
Updated:  2/14/2017
Parexel Early Phase Unit at Glendale
mi
from
Glendale, CA
Safety Study of LY3041658 in Healthy Participants
A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3041658 in Healthy Subjects
Status: Enrolling
Updated: 2/14/2017
Parexel Early Phase Unit at Glendale
mi
from
Glendale, CA
Click here to add this to my saved trials
A Study to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a Suspension of JNJ-54175446 in Healthy Male and Female Participants
A Randomized, Open-label, 2-Way Crossover, Parallel-group Study in Healthy Male and Female Subjects to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a Suspension of JNJ-54175446
Status: Enrolling
Updated:  2/15/2017
Clinical Research Facility
mi
from
Overland Park, KA
A Study to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a Suspension of JNJ-54175446 in Healthy Male and Female Participants
A Randomized, Open-label, 2-Way Crossover, Parallel-group Study in Healthy Male and Female Subjects to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a Suspension of JNJ-54175446
Status: Enrolling
Updated: 2/15/2017
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
The Psychobiological Effects of Participation in a One-Month Insight Meditation Retreat
The Psychobiological Effects of a One-Month Insight Meditation Retreat, a Sub-study of The Shamatha Project: A Longitudinal, Randomized Waitlist Control Study of Cognitive, Emotional, and Neural Effects of Intensive Meditation Training
Status: Enrolling
Updated:  2/16/2017
University of California Davis
mi
from
Davis, CA
The Psychobiological Effects of Participation in a One-Month Insight Meditation Retreat
The Psychobiological Effects of a One-Month Insight Meditation Retreat, a Sub-study of The Shamatha Project: A Longitudinal, Randomized Waitlist Control Study of Cognitive, Emotional, and Neural Effects of Intensive Meditation Training
Status: Enrolling
Updated: 2/16/2017
University of California Davis
mi
from
Davis, CA
Click here to add this to my saved trials
Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Subjects
A Two-Part Study to Evaluate the Effect of CYP3A4 Inhibition (Itraconazole-Part 1) and CYP1A2 Inhibition (Ciprofloxacin - Part 2) on the Single-Dose Pharmacokinetics of Pracinostat in Healthy Nonsmoking Subjects
Status: Enrolling
Updated:  2/22/2017
Celerion
mi
from
Tempe, AZ
Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Subjects
A Two-Part Study to Evaluate the Effect of CYP3A4 Inhibition (Itraconazole-Part 1) and CYP1A2 Inhibition (Ciprofloxacin - Part 2) on the Single-Dose Pharmacokinetics of Pracinostat in Healthy Nonsmoking Subjects
Status: Enrolling
Updated: 2/22/2017
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
Study to Evaluate the Food Effect of Single-dose Bioavailability of Pracinostat in Healthy Adult Subjects
A 2-Cohort Study to Evaluate the Effect of Food and the Effect of Cigarette Smoking on the Single-Dose Bioavailability of Pracinostat in Healthy Adult Subjects
Status: Enrolling
Updated:  2/22/2017
Celerion
mi
from
Tempe, AZ
Study to Evaluate the Food Effect of Single-dose Bioavailability of Pracinostat in Healthy Adult Subjects
A 2-Cohort Study to Evaluate the Effect of Food and the Effect of Cigarette Smoking on the Single-Dose Bioavailability of Pracinostat in Healthy Adult Subjects
Status: Enrolling
Updated: 2/22/2017
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers
A Trial to Examine the Bioequivalence of Norditropin® Versus Genotropin® in Healthy Adult Volunteers
Status: Enrolling
Updated:  2/23/2017
Novo Nordisk Investigational Site
mi
from
Evansville, IN
Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers
A Trial to Examine the Bioequivalence of Norditropin® Versus Genotropin® in Healthy Adult Volunteers
Status: Enrolling
Updated: 2/23/2017
Novo Nordisk Investigational Site
mi
from
Evansville, IN
Click here to add this to my saved trials
A Pharmacokinetic Study of MABp1 in Healthy Volunteers
A Phase I Pharmacokinetic Study of MABp1 in Healthy Volunteers
Status: Enrolling
Updated:  2/28/2017
XBiotech Investigative Site
mi
from
Austin, TX
A Pharmacokinetic Study of MABp1 in Healthy Volunteers
A Phase I Pharmacokinetic Study of MABp1 in Healthy Volunteers
Status: Enrolling
Updated: 2/28/2017
XBiotech Investigative Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Determine the Relative Bioavailability of a Tablet Formulation of GDC-0941 and the Effect of Ketoconazole on the Pharmacokinetics of the GDC-0941 Tablet
An Open-Label, 2-Part Study to Determine the Relative Bioavailability of a Tablet Formulation of GDC-0941 and the Effect of Ketoconazole on the Pharmacokinetics of the GDC-0941 Tablet
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Austin, TX
A Study to Determine the Relative Bioavailability of a Tablet Formulation of GDC-0941 and the Effect of Ketoconazole on the Pharmacokinetics of the GDC-0941 Tablet
An Open-Label, 2-Part Study to Determine the Relative Bioavailability of a Tablet Formulation of GDC-0941 and the Effect of Ketoconazole on the Pharmacokinetics of the GDC-0941 Tablet
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Aerosol Inhalation Treatment for Dyspnea
Aerosol Inhalation Treatment for Dyspnea
Status: Enrolling
Updated:  3/6/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Aerosol Inhalation Treatment for Dyspnea
Aerosol Inhalation Treatment for Dyspnea
Status: Enrolling
Updated: 3/6/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination
Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination
Status: Enrolling
Updated:  3/6/2017
Louisiana State University Health
mi
from
Shreveport, LA
Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination
Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination
Status: Enrolling
Updated: 3/6/2017
Louisiana State University Health
mi
from
Shreveport, LA
Click here to add this to my saved trials
Study to Evaluate the Effect of Diltiazem Extended Release on the Pharmacokinetics of E2027 in Healthy Subjects
An Open-label, Single-Sequence, Drug-Drug Interaction Study to Evaluate the Effect of Diltiazem Extended Release on the Pharmacokinetics of E2027 in Healthy Subjects
Status: Enrolling
Updated:  3/6/2017
Clinical Research Facility
mi
from
San Antonio, TX
Study to Evaluate the Effect of Diltiazem Extended Release on the Pharmacokinetics of E2027 in Healthy Subjects
An Open-label, Single-Sequence, Drug-Drug Interaction Study to Evaluate the Effect of Diltiazem Extended Release on the Pharmacokinetics of E2027 in Healthy Subjects
Status: Enrolling
Updated: 3/6/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult Participants
A Single-dose, Open-label, Randomized, Crossover Study to Assess the Relative Bioavailability of the Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Administered Orally as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Subjects
Status: Enrolling
Updated:  3/6/2017
Clinical Research Facility
mi
from
Tempe, AZ
Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult Participants
A Single-dose, Open-label, Randomized, Crossover Study to Assess the Relative Bioavailability of the Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Administered Orally as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Subjects
Status: Enrolling
Updated: 3/6/2017
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult and Elderly Subjects, and the Pharmacodynamics in Healthy Adult Subjects
A 4-Part, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult, Elderly and Japanese Subjects, and the Pharmacodynamics in Healthy Adult Subjects
Status: Enrolling
Updated:  3/7/2017
Paraxel International
mi
from
Glendale, CA
Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult and Elderly Subjects, and the Pharmacodynamics in Healthy Adult Subjects
A 4-Part, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult, Elderly and Japanese Subjects, and the Pharmacodynamics in Healthy Adult Subjects
Status: Enrolling
Updated: 3/7/2017
Paraxel International
mi
from
Glendale, CA
Click here to add this to my saved trials
Staccato Zaleplon Single Dose Pharmacokinetics
Safety, Tolerability, and Pharmacokinetics of a Single Dose of Staccato® Zaleplon for Inhalation in Healthy Volunteers
Status: Enrolling
Updated:  3/13/2017
Covance Clinical Research Unit Inc.
mi
from
Evansville, IN
Staccato Zaleplon Single Dose Pharmacokinetics
Safety, Tolerability, and Pharmacokinetics of a Single Dose of Staccato® Zaleplon for Inhalation in Healthy Volunteers
Status: Enrolling
Updated: 3/13/2017
Covance Clinical Research Unit Inc.
mi
from
Evansville, IN
Click here to add this to my saved trials
Transcranial Direct Stimulation in Chronic Pelvic Pain
Investigation and Treatment of Central Nervous System Dysfunction in Chronic Pelvic Pain.
Status: Enrolling
Updated:  3/14/2017
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Transcranial Direct Stimulation in Chronic Pelvic Pain
Investigation and Treatment of Central Nervous System Dysfunction in Chronic Pelvic Pain.
Status: Enrolling
Updated: 3/14/2017
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Caloric Stimulation on Cerebral Blood Flow
The Effect of Vestibular Stimulation on Cerebral Blood Flow
Status: Enrolling
Updated:  3/20/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Caloric Stimulation on Cerebral Blood Flow
The Effect of Vestibular Stimulation on Cerebral Blood Flow
Status: Enrolling
Updated: 3/20/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Bioequivalency Study Comparing Hospira's Generic Iron Sucrose Injection to Venofer
A Randomized, Open-Label, Single-Dose, Parallel-Design, Bioequivalence Study of Hospira Iron Sucrose Injection Compared to Venofer® Injection USP in Healthy Subjects.
Status: Enrolling
Updated:  3/20/2017
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Bioequivalency Study Comparing Hospira's Generic Iron Sucrose Injection to Venofer
A Randomized, Open-Label, Single-Dose, Parallel-Design, Bioequivalence Study of Hospira Iron Sucrose Injection Compared to Venofer® Injection USP in Healthy Subjects.
Status: Enrolling
Updated: 3/20/2017
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials
Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects
Investigation on Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects. A Randomised, Double-blind, Placebo-controlled Trial Investigating Subcutaneously Single Dose Escalation of a Sustained Release Formulation of Liraglutide Lysine in Healthy Male Subjects
Status: Enrolling
Updated:  3/22/2017
Novo Nordisk Investigational Site
mi
from
Evansville, IN
Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects
Investigation on Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects. A Randomised, Double-blind, Placebo-controlled Trial Investigating Subcutaneously Single Dose Escalation of a Sustained Release Formulation of Liraglutide Lysine in Healthy Male Subjects
Status: Enrolling
Updated: 3/22/2017
Novo Nordisk Investigational Site
mi
from
Evansville, IN
Click here to add this to my saved trials
Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195
Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195
Status: Enrolling
Updated:  3/23/2017
ICON Early Phase Services
mi
from
San Antonio, TX
Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195
Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195
Status: Enrolling
Updated: 3/23/2017
ICON Early Phase Services
mi
from
San Antonio, TX
Click here to add this to my saved trials
Molecular Phenotyping of Asthma in Sickle Cell Disease
Molecular Phenotyping of Asthma in Sickle Cell Disease
Status: Enrolling
Updated:  3/27/2017
Nemours Children's Clinic
mi
from
Wilmington, DE
Molecular Phenotyping of Asthma in Sickle Cell Disease
Molecular Phenotyping of Asthma in Sickle Cell Disease
Status: Enrolling
Updated: 3/27/2017
Nemours Children's Clinic
mi
from
Wilmington, DE
Click here to add this to my saved trials
Molecular Phenotyping of Asthma in Sickle Cell Disease
Molecular Phenotyping of Asthma in Sickle Cell Disease
Status: Enrolling
Updated:  3/27/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Molecular Phenotyping of Asthma in Sickle Cell Disease
Molecular Phenotyping of Asthma in Sickle Cell Disease
Status: Enrolling
Updated: 3/27/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Molecular Phenotyping of Asthma in Sickle Cell Disease
Molecular Phenotyping of Asthma in Sickle Cell Disease
Status: Enrolling
Updated:  3/27/2017
Nemours Children's Clinic
mi
from
Orlando, FL
Molecular Phenotyping of Asthma in Sickle Cell Disease
Molecular Phenotyping of Asthma in Sickle Cell Disease
Status: Enrolling
Updated: 3/27/2017
Nemours Children's Clinic
mi
from
Orlando, FL
Click here to add this to my saved trials
Open-Label Crossover Study Comparing CTP-543 to Jakafi®
An Open-Label Single-Dose Crossover Pharmacokinetic Study to Compare CTP-543 to Jakafi® in Healthy Volunteers
Status: Enrolling
Updated:  3/27/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Open-Label Crossover Study Comparing CTP-543 to Jakafi®
An Open-Label Single-Dose Crossover Pharmacokinetic Study to Compare CTP-543 to Jakafi® in Healthy Volunteers
Status: Enrolling
Updated: 3/27/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phase 1 Study of MGD010 in Healthy Subjects
A Phase 1, First-in-Human, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of MGD010, a CD32B x CD79B Dual Affinity Re-Targeting (DART®) Bi-specific Antibody-Based Molecule, in Healthy Subjects
Status: Enrolling
Updated:  3/28/2017
Parexel Baltimore Early Phase Clinical Unit
mi
from
Baltimore, MD
Phase 1 Study of MGD010 in Healthy Subjects
A Phase 1, First-in-Human, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of MGD010, a CD32B x CD79B Dual Affinity Re-Targeting (DART®) Bi-specific Antibody-Based Molecule, in Healthy Subjects
Status: Enrolling
Updated: 3/28/2017
Parexel Baltimore Early Phase Clinical Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
Stress, Coping and Health Behaviors in Pregnancy
Status: Enrolling
Updated:  3/29/2017
Nebraska Medicine
mi
from
Omaha, NE
Stress, Coping and Health Behaviors in Pregnancy
Status: Enrolling
Updated: 3/29/2017
Nebraska Medicine
mi
from
Omaha, NE
Click here to add this to my saved trials
To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food.
A Phase I, Open-label, Single-center, Sequential Design Study in Healthy Volunteers to Determine the Relative Bioavailability of Different Oral Formulations of AZD9291 and the Effect of Food
Status: Enrolling
Updated:  3/30/2017
Clinical Research Facility
mi
from
Overland Park, KA
To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food.
A Phase I, Open-label, Single-center, Sequential Design Study in Healthy Volunteers to Determine the Relative Bioavailability of Different Oral Formulations of AZD9291 and the Effect of Food
Status: Enrolling
Updated: 3/30/2017
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy Controls
An Open-label Mechanistic Study to Examine the Effect of Oral Empagliflozin (25 mg q.d.) on Kinetics of Renal Glucose Reabsorption in Patients With Type 2 Diabetes Mellitus and Healthy Controls
Status: Enrolling
Updated:  3/31/2017
Boehringer Ingelheim Investigational Site
mi
from
San Antonio, TX
Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy Controls
An Open-label Mechanistic Study to Examine the Effect of Oral Empagliflozin (25 mg q.d.) on Kinetics of Renal Glucose Reabsorption in Patients With Type 2 Diabetes Mellitus and Healthy Controls
Status: Enrolling
Updated: 3/31/2017
Boehringer Ingelheim Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety, Tolerability, PK of Oral NYX-2925 in Healthy Volunteers
A Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Daily Oral NYX2925 in Healthy Volunteers
Status: Enrolling
Updated:  4/4/2017
Spaulding Clinical
mi
from
West Bend, WI
Safety, Tolerability, PK of Oral NYX-2925 in Healthy Volunteers
A Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Daily Oral NYX2925 in Healthy Volunteers
Status: Enrolling
Updated: 4/4/2017
Spaulding Clinical
mi
from
West Bend, WI
Click here to add this to my saved trials
A Safety Study of Orally Administered BPM31510 in Healthy Subjects
A Phase I Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Orally Administered BPM31510 in Healthy Subjects
Status: Enrolling
Updated:  4/4/2017
Clinilabs, Inc.
mi
from
Eatontown, NJ
A Safety Study of Orally Administered BPM31510 in Healthy Subjects
A Phase I Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Orally Administered BPM31510 in Healthy Subjects
Status: Enrolling
Updated: 4/4/2017
Clinilabs, Inc.
mi
from
Eatontown, NJ
Click here to add this to my saved trials
Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy Subjects
A Single-Dose Study Evaluating the Oral Pharmacokinetics of an Oxycodone/Acetaminophen Solution in Healthy Subjects Under Fasted Conditions
Status: Enrolling
Updated:  4/4/2017
PPD, Phase 1 Clinic
mi
from
Austin, TX
Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy Subjects
A Single-Dose Study Evaluating the Oral Pharmacokinetics of an Oxycodone/Acetaminophen Solution in Healthy Subjects Under Fasted Conditions
Status: Enrolling
Updated: 4/4/2017
PPD, Phase 1 Clinic
mi
from
Austin, TX
Click here to add this to my saved trials